| A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease. | |
| | |
MedLine Citation:
|
PMID: 23166707 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Pro-inflammatory cytokines like macrophage migration inhibitory factor (MIF), IL-1β and TNF-α predominate in inflammatory bowel diseases (IBD) and TNBS colitis. Increased levels of serine proteases activating protease-activated receptor 2 (PAR-2) are found in the lumen and colonic tissue of IBD patients. PAR-2 activity and pro-inflammatory cytokines impair epithelial barrier, facilitating the uptake of luminal aggressors that perpetuate inflammation and visceral pain. Soy extracts contain phytoestrogens (isoflavones) and serine protease inhibitors namely Bowman-Birk Inhibitors (BBI). Since estrogens exhibit anti-inflammatory and epithelial barrier enhancing properties, and that a BBI concentrate improves ulcerative colitis, we aimed to evaluate if a fermented soy germ extract (FSG) with standardized isoflavone profile and stable BBI content exert cumulative or synergistic protection based on protease inhibition and estrogen receptor (ER)-ligand activity in colitic rats. Female rats received orally for 15 d either vehicle or FSG with or without an ER antagonist ICI 182.780 before TNBS intracolonic instillation. Macroscopic and microscopic damages, myeloperoxidase activity, cytokine levels, intestinal paracellular permeability, visceral sensitivity, faecal proteolytic activity and PAR-2 expression were assessed 24 h, 3 d and 5 d post-TNBS. FSG treatment improved the severity of colitis, by decreasing the TNBS-induced rise in gut permeability, visceral sensitivity, faecal proteolytic activity and PAR-2 expression at all post-TNBS points. All FSG effects were reversed by the ICI 182.780 except the decrease in faecal proteolytic activity and PAR-2 expression. In conclusion, the anti-inflammatory properties of FSG treatment result from two distinct but synergic pathways i.e an ER-ligand and a PAR-2 mediated pathway, providing rationale for potential use as adjuvant therapy in IBD. |
| | |
Authors:
|
Lara Moussa; Valérie Bézirard; Christel Salvador-Cartier; Valérie Bacquié; Corinne Lencina; Mathilde Lévêque; Viorica Braniste; Sandrine Ménard; Vassilia Théodorou; Eric Houdeau |
Related Documents
:
|
23480267 - Interleukin 4 as a potential drug candidate for psoriasis. 23523637 - The neuroinflammatory role of schwann cells in disease. 23144947 - Cxcl10 is critical for the generation of protective cd8 t cell response induced by anti... 23121887 - Bee venom ameliorates ovalbumin induced allergic asthma via modulating cd4(+)cd25(+) re... 19371137 - Purification, cloning, and functional characterization of a novel immunomodulatory prot... 10502547 - Cytokine regulation of a rodent model of mercuric chloride-induced autoimmunity. |
Publication Detail:
|
Type: Journal Article Date: 2012-11-14 |
Journal Detail:
|
Title: PloS one Volume: 7 ISSN: 1932-6203 ISO Abbreviation: PLoS ONE Publication Date: 2012 |
Date Detail:
|
Created Date: 2012-11-20 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101285081 Medline TA: PLoS One Country: United States |
Other Details:
|
Languages: eng Pagination: e49547 Citation Subset: IM |
Affiliation:
|
Neuro-Gastroenterology and Nutrition, Institut National de la Recherche Agronomique, UMR1331 Toxalim, INRA/INPT/UPS, Toulouse, France ; GENIBIO, Lorp-Sentaraille, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Origin of Oryza sativa in China Inferred by Nucleotide Polymorphisms of Organelle DNA.
Next Document: Serodiagnosis of Tuberculosis in Asian Elephants (Elephas maximus) in Southern India: A Latent Class...